These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: ADAP funding seen as insufficient; increases sought.
    Journal: AIDS Policy Law; 1997 May 02; 12(8):6. PubMed ID: 11364308.
    Abstract:
    Federal and State lawmakers are being asked to appropriate an additional $244.9 million this fiscal year and next to meet the growing demand for medicine through AIDS drug assistance programs (ADAPs). The ADAP Working Group revealed preliminary data indicating a widening gap between existing funding and projected needs of people with HIV who lack private insurance. A $66.9 million shortfall is expected in the current fiscal year. The projected spending needs for 1997 and 1998 are based on a survey of a pharmacoeconomic model that includes the rate of growth in applications to State ADAPs. The model takes into account future prescribing practices, assuming greater use of combination therapy using two nucleoside analogues and a protease inhibitor. Four States do not currently cover protease inhibitors and ten have capped access to new drugs. Despite rising costs for ADAPs, expenses could become even greater if people are denied access to medication.
    [Abstract] [Full Text] [Related] [New Search]